Dr. Yuko Nakajima, MD

Dr. Nakajima practices at Emory University Hospital in Atlanta, Georgia, part of Emory University.

Dr. Nakajima's NPI, 1043530355, was assigned on June 9, 2010. Dr. Nakajima holds California license A131474.

Dr. Nakajima's primary practice is Emory University Hospital, at 1364 Clifton Road, NE, Atlanta, GA 30322 in De Kalb County. The practice phone is (404) 686-8500.

Dr. Nakajima's primary practice is Emory University Hospital in Atlanta, Georgia, part of Emory University. Dr. Nakajima is also affiliated with Emory University Hospital Midtown. The medical group on file is Emory Clinic. Dmand AI also links Dr. Nakajima to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nakajima practices, 3 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Nakajima's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Nakajima is licensed in California.

CMS data shows 223 Medicare services from Dr. Nakajima across 5 procedure codes in 2024, for 148 Medicare patients. Medicare paid $18,898 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 148 Medicare patients who saw Dr. Nakajima in 2024. The largest group is 65 to 74, with 48 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 43% are also on Medicaid. Their average risk score is 3.11, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nakajima's median patient age at 59, with 64% women.

In 2024, Dr. Nakajima wrote 73 Medicare Part D claims for 45 patients. 84% of them were for generic drugs. CMS names the drug for 41 of them, across 3 drugs with 11 or more claims each, at $311 in total drug cost. In 2019, CMS named 29 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Nakajima for performance year 2024, reported through an alternative payment model (APM). Dr. Nakajima accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 3 general payments to Dr. Nakajima from 2 drug and device companies from 2017 to 2018. Consulting fees make up the largest share, 96% of the total. Teleflex Medical Japan, Ltd. paid the most, $934.